Loss of miR-6844 alters stemness/self-renewal and cancer hallmark(s) markers through CD44-JAK2-STAT3 signaling axis in breast cancer stem-like cells
- PMID: 37436061
- DOI: 10.1002/jcb.30441
Loss of miR-6844 alters stemness/self-renewal and cancer hallmark(s) markers through CD44-JAK2-STAT3 signaling axis in breast cancer stem-like cells
Abstract
MicroRNAs regulate breast stemness and self-renewal properties in breast cancer cells at the molecular level. Recently we reported the clinical relevance and in vitro expression profile of novel miR-6844 in breast cancer and -derived stem-like cells (mammosphere). In the present study, we first time explore the functional role of loss of miR-6844 in breast cancer cells derived mammosphere. Down expression of miR-6844 significantly decreased cell proliferation in MCF-7 and T47D cells derived mammosphere in a time-dependent manner. MiR-6844 down expression reduced the sphere formation in terms of size and number in test cells. Loss of miR-6844 significantly altered stemness and self-renewal markers (Bmi-1, Nanog, c-Myc, Sox2, and CD44) in mammosphere compared to negative control spheres. Moreover, loss of miR-6844 inhibits the JAK2-STAT3 signaling pathway by decreasing p-JAK2 and p-STAT3 levels in breast cancer cells derived mammosphere. Loss of miR-6844 expression significantly decreased CCND1 and CDK4 mRNA/protein levels and arrested breast cancer stem-like cells in G2/M phase. Reduced expression of miR-6844 increased Bax/Bcl-2 ratio, late apoptotic cell population, and Caspase 9 and 3/7 activity in the mammosphere. Low expression of miR-6844 decreased migratory and invasive cells by altering the expression of Snail, E-cad, and Vimentin at mRNA/protein levels. In conclusion, loss of miR-6844 decreases stemness/self-renewal and other cancer hallmark in breast cancer stem-like cells through CD44-JAK2-STAT3 axis. Thus, downregulation of miR-6844 by therapeutic agents might be a novel strategy to target breast cancer stemness and self-renewal.
Keywords: apoptosis; breast cancer stem-like cells; cell cycle; metastasis/Invasion; microRNA.
© 2023 Wiley Periodicals LLC.
Similar articles
-
Kurarinone targets JAK2-STAT3 signaling in colon cancer-stem-like cells.Cell Biochem Funct. 2024 Mar;42(2):e3959. doi: 10.1002/cbf.3959. Cell Biochem Funct. 2024. PMID: 38390770
-
Pentadecanoic Acid, an Odd-Chain Fatty Acid, Suppresses the Stemness of MCF-7/SC Human Breast Cancer Stem-Like Cells through JAK2/STAT3 Signaling.Nutrients. 2020 Jun 3;12(6):1663. doi: 10.3390/nu12061663. Nutrients. 2020. PMID: 32503225 Free PMC article.
-
MiR-375 inhibits the stemness of breast cancer cells by blocking the JAK2/STAT3 signaling.Eur J Pharmacol. 2020 Oct 5;884:173359. doi: 10.1016/j.ejphar.2020.173359. Epub 2020 Jul 30. Eur J Pharmacol. 2020. PMID: 32738343
-
Anti-miR-203 suppresses ER-positive breast cancer growth and stemness by targeting SOCS3.Oncotarget. 2016 Sep 6;7(36):58595-58605. doi: 10.18632/oncotarget.11193. Oncotarget. 2016. PMID: 27517632 Free PMC article. Review.
-
Triterpene Acid (3-O-p-Coumaroyltormentic Acid) Isolated From Aronia Extracts Inhibits Breast Cancer Stem Cell Formation through Downregulation of c-Myc Protein.Int J Mol Sci. 2018 Aug 26;19(9):2528. doi: 10.3390/ijms19092528. Int J Mol Sci. 2018. PMID: 30149665 Free PMC article. Review.
References
REFERENCES
-
- Wang R, Lv Q, Meng W, et al. Comparison of mammosphere formation from breast cancer cell lines and primary breast tumors. J Thorac Dis. 2014;6(6):829-837. doi:10.3978/j.issn.2072-1439.2014.03.38
-
- Dontu G, Abdallah WM, Foley JM, et al. In vitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev. 2003;17(10):1253-1270. doi:10.1101/gad.1061803
-
- Ponti D, Costa A, Zaffaroni N, et al. Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties. Cancer Res. 2005;65(13):5506-5511. doi:10.1158/0008-5472
-
- Marotta LLC, Almendro V, Marusyk A, et al. The JAK2/STAT3 signaling pathway is required for growth of CD44⁺CD24⁻ stem cell-like breast cancer cells in human tumors. J Clin Invest. 2011;121(7):2723-2735. doi:10.1172/JCI44745
-
- Naor D, Nedvetzki S, Golan I, Melnik L, Faitelson Y. CD44 in cancer. Crit Rev Clin Lab Sci. 2002;39(6):527-579. doi:10.1080/10408360290795574
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous